Adjuvant FOLFOX treatment for stage III colon cancer: how many cycles are enough?

PURPOSE: Adjuvant FOLFOX (5-fluorouracil and oxaliplatin) chemotherapy benefits stage III colon cancer patients. However, it still results in side effects and increased cost. Reducing cycles had been thought to decrease these problems. This retrospective study aimed to find the appropriate number of...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Yi-Jian, Lin, Jen-Kou, Chen, Wei-Shone, Jiang, Jeng-Kai, Teng, Hao-Wei, Yen, Chueh-Chuan, Lin, Tzu-chen, Yang, Shung-Haur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980863/
https://www.ncbi.nlm.nih.gov/pubmed/27563513
http://dx.doi.org/10.1186/s40064-016-2976-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980863/
https://www.ncbi.nlm.nih.gov/pubmed/27563513
http://dx.doi.org/10.1186/s40064-016-2976-9

Ejemplares similares